Ubs Asset Management Americas Inc Silverback Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 247,314 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
247,314
Previous 234,537
5.45%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SBTX
# of Institutions
178Shares Held
70MCall Options Held
218KPut Options Held
329K-
Ra Capital Management, L.P. Boston, MA10.9MShares$00.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY10.5MShares$00.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA8.29MShares$00.0% of portfolio
-
Black Rock Inc. New York, NY4.08MShares$00.0% of portfolio
-
Sr One Capital Management, LP4.01MShares$00.0% of portfolio
About Silverback Therapeutics, Inc.
- Ticker SBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,473,800
- Description
- Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...